Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993-2017

被引:102
作者
Montastruc, Francois [1 ]
Loo, Simone Y. [2 ]
Renoux, Christel [2 ]
机构
[1] Ctr Hosp Univ, Serv Pharmacol Med & Clin, Toulouse, France
[2] McGill Univ, Ctr Clin Epidemiol, Montreal, PQ, Canada
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 320卷 / 20期
关键词
D O I
10.1001/jama.2018.12358
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2149 / 2151
页数:4
相关论文
共 6 条
[1]   Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study [J].
Gomes, Tara ;
Juurlink, David N. ;
Antoniou, Tony ;
Mamdani, Muhammad M. ;
Paterson, J. Michael ;
van den Brink, Wim .
PLOS MEDICINE, 2017, 14 (10)
[2]   Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern? [J].
Goodman, Christopher W. ;
Brett, Allan S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (05) :411-414
[3]   Data Resource Profile: Clinical Practice Research Datalink (CPRD) [J].
Herrett, Emily ;
Gallagher, Arlene M. ;
Bhaskaran, Krishnan ;
Forbes, Harriet ;
Mathur, Rohini ;
van Staa, Tjeerd ;
Smeeth, Liam .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (03) :827-836
[4]  
IACOBUCCI G, 2017, BMJ-BRIT MED J, V358, P1454, DOI DOI 10.1136/BMJ.J4441
[5]   Gabapentinoid Use in the United States 2002 Through 2015 [J].
Johansen, Michael E. .
JAMA INTERNAL MEDICINE, 2018, 178 (02) :292-294
[6]   Gabapentin Approvals, Off-Label Use, and Lessons for Postmarketing Evaluation Efforts [J].
Wallach, Joshua D. ;
Ross, Joseph S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (08) :776-778